Post by UCB

🔦 Publication Highlight 🔦 Clinical trials are the cornerstone of medical progress, but they have traditionally followed a model that can be demanding for participants. Asking people, who are often managing health conditions, to travel frequently to specific sites can create significant burdens and limit access for many. As we look toward a more inclusive and efficient future for healthcare, we must ask ourselves: how can we bring research closer to the people it is meant to serve? The answer may lie in decentralized clinical trials (DCTs), a model that uses technology and local resources to allow participants to join studies from the comfort of their homes. While the concept is powerful, putting it into practice across different countries, each with its own rules, presents a complex puzzle. We’re proud to spotlight the important work of our UCB colleagues Hamidou Traore and Tim De Smedt, alongside their collaborators, in the paper: Regulatory Interactions and Learnings—RADIAL, the Trials@Home proof-of-concept trial on decentralization. It shares invaluable lessons learned from the RADIAL trial, a study designed to test the feasibility of decentralized methods across Europe. This work is a blueprint for building a more patient-centered and globally harmonized future for clinical research. At its core, this work is about making clinical research more patient-centric, more inclusive, and more practical in real life. RADIAL also highlights the power of collaboration across the research ecosystem. This was not the work of one team alone, but brought together industry, regulators, academic institutions, and other stakeholders to explore how decentralized clinical trials can work across borders and systems. AI tools were used to support the animation and voiceover development. #ClinicalTrials #PatientCentricity #DecentralizedTrials

Video Content